GlaxoSmithKline Research & Development Limited
⚠️ High Risk
FEI: 3003284850 • Stevenage, Hertfordshire • UNITED KINGDOM
FEI Number
3003284850
Location
Stevenage, Hertfordshire
Country
UNITED KINGDOMAddress
Gunnels Wood Road, , Stevenage, Hertfordshire, United Kingdom
High Risk
FDA Import Risk Assessment
This firm has a significant history of FDA import refusals with notable violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 9/24/2025 | 61XDQ50AZELASTINE HYDROCHLORIDE/FLUTICASONE, ANTI-HISTAMINE STEROID (ANTI-HISTAMINIC) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 5/13/2022 | 60CAY53XYLOMETAZOLINE HCL (ADRENERGIC) | Division of Southeast Imports (DSEI) | |
| 1/4/2021 | 56YCY99ANTIBIOTIC N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 4/30/2014 | 60LCA88SUMATRIPTAN (ANALGESIC) | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 6/21/2011 | 66VCC99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 6/21/2011 | 66VCC99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 6/21/2011 | 66VCC99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
Frequently Asked Questions
What is GlaxoSmithKline Research & Development Limited's FDA import refusal history?
GlaxoSmithKline Research & Development Limited (FEI: 3003284850) has 7 FDA import refusal record(s) in our database, spanning from 6/21/2011 to 9/24/2025.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. GlaxoSmithKline Research & Development Limited's FEI number is 3003284850.
What types of violations has GlaxoSmithKline Research & Development Limited received?
GlaxoSmithKline Research & Development Limited has been cited for 2 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about GlaxoSmithKline Research & Development Limited come from?
All FDA import refusal data for GlaxoSmithKline Research & Development Limited is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.